JoinAStudy.ca Investigator Dr. Anil Gupta was recently asked to assist in the presentation of strategies for preventing COVID progression and transmission in the outpatient setting, including the latest therapeutic developments. This effort was supported by an educational grant from Merck Sharp & Dohme Corp. The presentation linked below will define the sub-populations that are most
Canada has approved the first oral COVID-19 treatment that can be taken at home. The drug, an antiviral developed by Pfizer, was found to reduce risk of hospitalization and death by 89 percent in clinical trials. At the moment, there is a “limited global supply” of the drug, thus Canadian health officials have prioritized the
Earlier this year, we reported on the positive findings of a Covid-19 treatment study, conducted by lead study author and JoinAStudy Investigator Dr. Anil Gupta. We are now proud to highlight that as of November 18, 2021 this research has been published in the prestigious New England Journal of Medicine. It is among the most reputable peer-reviewed medical
Analysis of data from 6.2 million people has found no significant associations between mRNA COVID-19 vaccines and serious side effects. The study authors, based in cities across the United States, undertook this study to compare mRNA vaccines’ negative effects in the first 21 days post-vaccination to negative effects occurring 22 days + after vaccination. Safe and
New research suggests that COVID-19 lockdowns led to 95,000 fewer air pollution-related deaths globally. Business closures and stay-at-home orders were the main drivers behind up to a 50% reduction in airborne concentrations of nitrogen dioxide, a direct emission from vehicles and coal-powered electricity plants. The greatest reduction in microscopic particulate matter released into the air
UPDATE 28/10/2021 Dr. Gupta’s work as lead researcher on this study has been published in The New England Journal of Medicine, in an article titled Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab. You can find a link to the article on The Journal‘s website, here: https://www.nejm.org/doi/full/10.1056/NEJMoa2107934?query=featured_home UPDATE 30/8/2021 Dr. Gupta has given two
